Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Carlson Resigns From Obagi Medical Products - Happi
Company News

Carlson Resigns From Obagi Medical Products

Albert F. Hummel named interim president/CEO.

Obagi Medical Products, Inc. announced today that president and chief executive officer Steven R. Carlson has resigned, effective immediately, from those posts and from the company’s board of directors. Albert F. Hummel, a director who has been with the company since 2005, has been appointed as interim president and chief executive officer.

“The board thanks Steve Carlson for his more than five years of service, during which time the Company completed its successful initial public offering, developed and introduced several new products and saw its annual sales revenues grow from $56 million to $104 million,” said board chairman Albert J. Fitzgibbons.

Calling Hummel a “proven manager and seasoned executive” with experience in pharmaceuticals and dermatology, Fitzgibbons added, “We believe he is a person who will ably guide the company through a period of management transition.”

Hummel has nearly 40 years of diverse business and capital markets experience; he is chief executive officer and a director of Cobrek Pharmaceuticals, Inc., a privately held pharmaceutical product development company located in Chicago.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters